Wolverine Asset Management LLC Humacyte, Inc. Transaction History

Wolverine Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$2.57 - $4.84 $4,407 - $8,300	1,715 New	1,715 $5,000
Q2 2023 Aug 07, 2023	SELL	$2.86 - $4.97 $3,992 - $6,938	-1,396 Reduced 55.22%	1,132 $3,000
Q1 2023 May 08, 2023	SELL	$2.11 - $3.25 $5,473 - $8,430	-2,594 Reduced 50.64%	2,528 $7,000
Q4 2022 Feb 01, 2023	SELL	$2.02 - $3.62 $9,186 - $16,463	-4,548 Reduced 47.03%	5,122 $10,000
Q3 2022 Nov 10, 2022	SELL	$1.22 - $5.14 $1,220 - $5,140	-1,000 Reduced 9.37%	9,670 $31,000
Q2 2022 Aug 03, 2022	SELL	$3.21 - $7.86 $1,743 - $4,267	-543 Reduced 4.84%	10,670 $34,000
Q1 2022 May 04, 2022	SELL	$4.65 - $7.4 $9,007 - $14,333	-1,937 Reduced 14.73%	11,213 $79,000
Q4 2021 Feb 09, 2022	BUY	$7.25 - $11.6 $95,337 - $152,540	13,150 New	13,150 $95,000

149

35.1M

279K

607K

Ticker HUMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,007,000
Market Cap $454M
Description
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.